Disc Medicine Stock (NASDAQ:IRON), Quotes and News Summary

Q: What sector and industry does Disc Medicine (IRON) operate in?

Disc Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Disc Medicine Stock (NASDAQ: IRON) stock price, news, charts, stock research, profile.

Open	$31.790
Close	-
Volume / Avg.	142.088K / 491.993K
Day Range	31.100 - 32.250
52 Wk Range	25.600 - 77.600
Market Cap	$791.217M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	7.91%
Days to Cover	4.4

Recent News

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc.

Zacks

Top 3 Health Care Stocks You'll Regret Missing This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Avi Kapoor

Gold Gains 1%; CXApp Shares Spike Higher

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.3% on Monday. The Dow traded down 0.67% to 39,538.91 while the NASDAQ fell 0.06% to 16,369.44. The S&P 500 also fell, dropping, 0.30% to 5,238.49.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Disc Medicine Inc

Sector

Health Care

Industry

Biotechnology

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Disc Medicine (IRON) stock?

You can purchase shares of Disc Medicine (NASDAQ: IRON) through any online brokerage.

View our list of the best stock brokerages.

Who are Disc Medicine's (IRON) competitors?

Other companies in Disc Medicine’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), Zentalis Pharma (NASDAQ:ZNTL) and Cogent Biosciences (NASDAQ:COGT).

What is the target price for Disc Medicine (IRON) stock?

The latest price target for Disc Medicine (NASDAQ: IRON) was reported by Cantor Fitzgerald on Wednesday, May 15, 2024. The analyst firm set a price target for 85.00 expecting IRON to rise to within 12 months (a possible 165.58% upside). 24 analyst firms have reported ratings in the last year.

Current Stock Price for Disc Medicine (IRON)?

The stock price for Disc Medicine (NASDAQ: IRON) is $32.005 last updated Today at May 16, 2024 at 3:44 PM EDT.

Does Disc Medicine (IRON) pay a dividend?

There are no upcoming dividends for Disc Medicine.

When is Disc Medicine (NASDAQ:IRON) reporting earnings?

Disc Medicine’s Q2 earnings are confirmed for Friday, August 9, 2024.

Is Disc Medicine (IRON) going to split?

There is no upcoming split for Disc Medicine.

What sector and industry does Disc Medicine (IRON) operate in?

Disc Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-